Results 11 to 20 of about 10,052 (132)

Surgical Result for Patients Who Simultaneously Presented With Myasthenia Gravis and Thymoma [PDF]

Thoracic Cancer
Background Patients who present concurrently with thymoma and myasthenia gravis (MG) constitute a unique clinical population in whom both oncologic control and stabilization of MG symptoms are essential treatment goals.
Po‐Chun Chang, Ping‐Chung Tsai, Ching‐Feng Wu, Yau‐Lin Tseng, En‐Kuei Tang, Tzu‐Ping Chen, Yi‐Ting Yen, Ching‐Yang Wu   +7 more
doaj   +2 more sources

Myasthenia Gravis and Thymoma. [PDF]

Muscle Nerve
ABSTRACT Thymoma is the most common tumor of the anterior mediastinum. Approximately 20%–30% of patients with a thymoma develop myasthenia gravis (MG), and an additional one third may possess positive acetylcholine receptor (AChR) antibodies without MG.
Claytor B, Delasos L, Raymond DP, Seroogy E, Lempel J, Li Y.   +5 more
europepmc   +2 more sources

Real‐World Clinical Outcomes and Corticosteroid Tapering in Telitacicept‐Based Therapy for Ocular Myasthenia Gravis: An Exploratory Analysis by Prior Treatment History [PDF]

Brain Behav
ABSTRACT Introduction Ocular myasthenia gravis (OMG) is an autoantibody‐mediated disease characterized by extraocular muscle weakness. Telitacicept has shown potential in treating autoimmune diseases, but its efficacy and corticosteroid‐tapering outcomes in OMG remain unexamined.
Xie S, Song W, Guo R, Li C, Zhang M, Cheng Y, Guo W, Jin B, Li J, Wang Y.   +9 more
europepmc   +2 more sources

Immune remodeling after thymectomy in patients with anti-AChR antibodies [PDF]

Frontiers in Immunology
BackgroundThymectomy is an established treatment for thymoma-associated myasthenia gravis (MG). However, a subset of patients develop new-onset MG after surgery.
Naoshi Koizumi, Makoto Kinoshita, Makoto Kinoshita, Makoto Kinoshita, Yoshiaki Yasumizu, Tomohiro Yata, Daisuke Motooka, Daisuke Motooka, Ryohei Yamamura, Itsuki Sano, Yu Suzuki, Akihiro Tanaka, Minami Kanakura, Toru Koda, Naoko Ose, Takashi Kanou, Kenji Kimura, Yasushi Shintani, Hideki Mochizuki, Hideki Mochizuki, Tatsusada Okuno   +20 more
doaj   +2 more sources

Survival and Autoimmune Risks Post-Thymectomy

Frontiers in Immunology
Background and objectivesRecent studies have raised concerns about thymectomy's deleterious effects. However, this conclusion was not exclusive to patients with myasthenia gravis (MG). The objective of this study was to test this hypothesis in thymectomy
Dvir Aran
exaly   +3 more sources

Combined minimally invasive direct coronary artery bypass with video-assisted thoracoscopic surgery thymectomy via left anterolateral mini-thoracotomy [PDF]

Journal of Cardiothoracic Surgery
Minimally invasive surgery (MIS) has become increasingly prevalent across almost all surgical specialties, including cardiothoracic surgery. However, combined MIS for coronary artery bypass and thymectomy in a single sitting has not been previously ...
Leng Khoong Lee, Marco Lizwan, Kim Chai Chua, Cynthia Ming Li Chia   +3 more
doaj   +2 more sources

The neurological outcome in the patients with myasthenia gravis who underwent thymectomy via sternotomy and video-assisted thoracoscopic surgery (VATS) [PDF]

Vojnosanitetski Pregled, 2021
Background/Aim. Thymectomy is accepted in the surgical treatment of the patients with myasthenia gravis (MG). Earlier thymectomy via sternotomy has recently been replaced by video-assisted thoracoscopic surgery (VATS), which is less invasive.
Martić Vesna, Marić Nebojša, Cvijanović Vlado   +2 more
doaj   +1 more source

Anti–pituitary-specific transcription factor-1 hypophysitis developing after thymoma resection: a case report with review of literature [PDF]

Endocrine Journal
Anti–pituitary-specific transcription factor-1 (PIT-1) hypophysitis is an acquired autoimmune disorder characterized by selective deficiencies of growth hormone (GH), prolactin (PRL), and thyrotropin (TSH).
Hitomi Konishi, Yui Yamashita, Yuma Motomura, Shin Urai, Yumiko Sasai, Keiko Yamagami, Hironori Bando, Naotetsu Kanamoto   +7 more
doaj   +2 more sources

Thoracoscopic versus classic trans-sternal thymectomy for myasthenia gravis: single-center experience. [PDF]

Zagazig University Medical Journal, 2022
Background: Myasthenia gravis (MG) is a neuromuscular junction autoimmune disorder that has a great impact on quality of life. Thymectomy can be approached by classic trans-sternal or thoracoscopic thymectomy. This study aimed to assess the perioperative
Abdelmeged Salem, Noor Al Jabri, Adil Al Kindi, Ehab Sobhy   +3 more
doaj   +1 more source

Robotic thymectomy: a review of techniques and results

Polish Journal of Thoracic and Cardiovascular Surgery, 2023
Thymectomy is a well-established therapeutic option in the multidisciplinary treatment of nonthymomatous myasthenia gravis (MG) and in thymoma treatment.
Danilo Coco, Silvana Leanza
doaj   +1 more source